190 related articles for article (PubMed ID: 14561392)
1. Prophylactic use of myelopoietic growth factors in children after myelosuppressive and myeloablative therapy.
Satwani P; Bessmertny O; Morris E; Cairo MS
Curr Hematol Rep; 2003 Nov; 2(6):480-90. PubMed ID: 14561392
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic growth factors in bone marrow transplantation.
Mertelsmann R; Herrmann F; Hecht T; Schulz G
Bone Marrow Transplant; 1990 Aug; 6(2):73-7. PubMed ID: 1698494
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic growth factors in autologous bone marrow transplantation.
Miller AM
Semin Oncol; 1993 Oct; 20(5 Suppl 6):88-95. PubMed ID: 7692607
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
[TBL] [Abstract][Full Text] [Related]
7. Growth factors in allogeneic transplantation.
Nemunaitis J
Semin Oncol; 1993 Oct; 20(5 Suppl 6):96-101. PubMed ID: 8211221
[TBL] [Abstract][Full Text] [Related]
8. [Current status of clinical indications for hematopoietic growth factors after chemo-/radiotherapy in gynecology].
Karthaus M; Ganser A
Zentralbl Gynakol; 1997; 119(12):585-96. PubMed ID: 9483809
[TBL] [Abstract][Full Text] [Related]
9. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
10. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic growth factors in cancer chemotherapy.
Morstyn G; Foote M; Lieschke GJ
Cancer Chemother Biol Response Modif; 1996; 16():295-314. PubMed ID: 8639388
[No Abstract] [Full Text] [Related]
12. The therapeutic use of hematopoietic growth factors.
Costa JJ
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
[No Abstract] [Full Text] [Related]
13. Granulocyte colony-stimulating factor after autologous CD34+ immunoselected peripheral blood stem cell transplantation.
Piccirillo N; De Matteis S; Sorà F; d'Onofrio G; Leone G; Sica S
Haematologica; 2004 Sep; 89(9):1144-6. PubMed ID: 15377480
[TBL] [Abstract][Full Text] [Related]
14. Colony-stimulating factors in the management of neutropenia and its complications.
Heuser M; Ganser A
Ann Hematol; 2005 Oct; 84(11):697-708. PubMed ID: 16047204
[TBL] [Abstract][Full Text] [Related]
15. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.
Bennett CL; Evens AM; Andritsos LA; Balasubramanian L; Mai M; Fisher MJ; Kuzel TM; Angelotta C; McKoy JM; Vose JM; Bierman PJ; Kuter DJ; Trifilio SM; Devine SM; Tallman MS
Br J Haematol; 2006 Dec; 135(5):642-50. PubMed ID: 17054431
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose?
Elfenbein GJ
Pediatr Transplant; 2005 Dec; 9 Suppl 7():37-47. PubMed ID: 16305616
[TBL] [Abstract][Full Text] [Related]
17. [Hematopoietic growth factors in oncology and hematology. Recommendations for more cost-efficient use].
Paul C; Hast R
Lakartidningen; 2000 Jun; 97(23):2862-6. PubMed ID: 10885223
[No Abstract] [Full Text] [Related]
18. [Prophylactic use of hematopoietic growth factors (G-CSF, GM-CSF) in prevention of chemotherapy-induced myelosuppression in children].
Osińska-Królak M; Kurylak A; Wysocki M; Kurylak D; Kindracka A; Balcar-Boroń A
Wiad Lek; 2003; 56(3-4):152-6. PubMed ID: 12923962
[TBL] [Abstract][Full Text] [Related]
19. The role of cytokines following bone marrow transplantation: indications and controversies.
Weinthal JA
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S10-4. PubMed ID: 8971400
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of myeloid growth factors in cancer chemotherapy.
Lyman GH; Kuderer NM
Curr Hematol Rep; 2003 Nov; 2(6):471-9. PubMed ID: 14561391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
